- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07927439
Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic
Investigating the Acute and Long-term Effects of Treadmill-integrated Virtual Reality (VR) Training on Real-World Mobility and Fall-Related Outcomes in People With Multiple Sclerosis
This study will test whether a treadmill-based virtual reality walking program is safe, practical, and helpful for people with multiple sclerosis (MS). Participants will complete a 6-week training program and wear smart socks that measure how they walk before, during, and after the program. The study will also track changes in balance, fatigue, fall risk, fear of falling, confidence with walking, and overall quality of life.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
People with multiple sclerosis (MS) often have trouble with walking and balance, which can increase the risk of falls and make daily life harder. While therapy can improve walking in a clinic, it is not always clear if those improvements carry over to real life at home or in the community. In addition, most walking tests are done over short periods and may not show how a person moves throughout the day. This study will look at new ways to better understand and improve walking in everyday settings. Researchers will use a treadmill-based virtual reality program, along with smart socks that track walking during daily activities. This approach will help show how people respond to training and whether those changes last outside the clinic. Standard care for people with MS usually includes physical therapy and clinic-based walking tests, but these may miss important changes in daily movement.
Participants will be asked to provide basic health information and complete surveys about their walking, fatigue, balance, thinking, and quality of life at different times during the study. They will also complete simple walking and balance tests to measure their mobility. As part of the study, participants will take part in a 6-week treadmill-based virtual reality training program, with two sessions each week. During the study, they will wear smart socks that collect information about how they walk in their daily lives, including before, during, and after the training program. These socks will track how often they walk, how steady they are, and how their walking changes over time. After the training ends, participants will continue wearing the socks for several weeks so researchers can see if improvements last. The results will help researchers learn if this approach can improve walking, lower fall risk, and support better mobility and quality of life for people living with MS.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Julie F Stowell, DPT
- Numéro de téléphone: 4046035049
- E-mail: julie.stowell@shepherd.org
Lieux d'étude
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30309
- Recrutement
- Shepherd Center
-
Contact:
- Julie F Stowell, DPT
- Numéro de téléphone: 404-603-5049
- E-mail: julie.stowell@shepherd.org
-
Chercheur principal:
- Julie F Stowell, DPT
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Have a clinically confirmed diagnosis of multiple sclerosis (MS).
- Be 18 years of age or older.
- Demonstrate ≥10% variability in stride length, step length, or gait asymmetry.
- Can ambulate without an assistive device, with a unilateral, or with a bilateral assistive device.
- Demonstrate no more than mild cognitive impairment, indicated by the Mini-Mental State Exam (score >19).
- Possess adequate cognitive function to understand and follow research instructions.
- Be able to safely participate in the study and training procedures as determined by study staff.
- Be fluent in English and able to communicate discomfort, fatigue, or pain in English.
- Be able to travel to Shepherd Center to complete key assessment points in-person and for in-person training sessions twice per week.
Exclusion Criteria:
- Have a diagnosis of any other neurological condition or recent orthopedic conditions that affects gait, balance, or mobility.
- Exhibit <10% variability in stride length, step length, or gait asymmetry.
- Are unable to ambulate (i.e. wheelchair bound or bedbound individuals).
- Have legal blindness or severe visual impairment that would interfere with virtual reality engagement or safe ambulation.
- Have a body weight exceeding 300 lbs., which exceeds the safety limits of the treadmill and body weight support system.
- Have uncontrolled or untreated hypertension, hypotension, or angina.
- Have a past or current history of epilepsy or any other type of seizure disorder, whether controlled or uncontrolled.
- Have undergone major surgery within the past 6 months or hospitalization within the past 3 months.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm 1
Gait training |
6-week training program with 2 training sessions each week |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
step length (m) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
stride length (m) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
step time (s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
single support time (s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
double support time (s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
gait cycle (s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
cadence (steps/s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
stance time (s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
speed(m/s) |
Initial visit to the end of the program in 12 weeks
|
|
Spatiotemporal metrics of gait
Délai: Initial visit to the end of the program in 12 weeks
|
swing time (s) |
Initial visit to the end of the program in 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Fear of falling (FOF)
Délai: Surveys will be conducted at the initial visit, week 2, 5, 8, and 12.
|
FOF as determined by Falls Efficacy Scale-International (FES-I); Scale: Not at all concerned = 1, Somewhat concerned = 2, Fairly concerned = 3, Very concerned = 4; Lowest score = 16, Highest score = 64, lower scores indicated less FOF (better), higher scores indicated more FOF (worse), total score divided by 64. |
Surveys will be conducted at the initial visit, week 2, 5, 8, and 12.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1111
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Shepherd Center will publish findings as appropriate and will maintain confidential records as necessary.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .